Find out about BPC-157 and TB-500, including what they're promoted for and if they're safe
The FDA label includes a boxed warning regarding thyroid C-cell tumors observed in rodent studies, contraindicating use in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Theyre based on individual reports from peptide users and the clinicians who recommend them, lacking visibility into the doses used, the frequency, or severity of the symptoms
The FDA explains that compounded drugs are not FDA-approved , meaning the agency does not verify their safety, effectiveness, or quality before marketing (see Compounding and the FDA: Questions and Answers )
Even if a site advertises third-party testing, theres no oversight or enforcement